One year outcomes after glucose–insulin–potassium in ST elevation myocardial infarction. The Glucose–insulin–potassium study II
- 1 October 2007
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 122 (1) , 52-55
- https://doi.org/10.1016/j.ijcard.2006.11.037
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Glucose-Insulin-Potassium Infusion in Patients With Acute Myocardial Infarction Without Signs of Heart Failure: The Glucose-Insulin-Potassium Study (GIPS)-IIJournal of the American College of Cardiology, 2006
- Glucose-insulin-potassium and reperfusion in acute myocardial infarction: Rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)American Heart Journal, 2005
- Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary eventsEuropean Heart Journal, 2005
- A challenge to the metabolic approach to myocardial ischaemiaEuropean Heart Journal, 2005
- Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityEuropean Heart Journal, 2005
- Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial InfarctionJAMA, 2005
- Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: a randomized trialJournal of the American College of Cardiology, 2003
- Metabolic Modulation of Acute Myocardial InfarctionCirculation, 1998
- Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial InfarctionCirculation, 1997
- Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 yearJournal of the American College of Cardiology, 1995